Lilly Asia Ventures Fund II, L.P. - Net Worth and Insider Trading

Lilly Asia Ventures Fund II, L.P. Net Worth

The estimated net worth of Lilly Asia Ventures Fund II, L.P. is at least $53 Million dollars as of 2025-06-06. Lilly Asia Ventures Fund II, L.P. is the 2201 Interest of corporation controlled by you of MicroTech Medical (Hangzhou) Co Ltd and owns about 8,545,840 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) stock worth over $53 Million. Details can be seen in Lilly Asia Ventures Fund II, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lilly Asia Ventures Fund II, L.P. has not made any transactions after 2024-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Lilly Asia Ventures Fund II, L.P.

Lilly Asia Ventures Fund II, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lilly Asia Ventures Fund II, L.P. owns 1 companies in total, including MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) .

Click here to see the complete history of Lilly Asia Ventures Fund II, L.P.’s form 4 insider trades.

Insider Ownership Summary of Lilly Asia Ventures Fund II, L.P.

Ticker	Company	Transaction Date	Type of Owner
HKSE:02235	MicroTech Medical (Hangzhou) Co Ltd	2024-05-28	2201 Interest of corporation controlled by you

Lilly Asia Ventures Fund II, L.P. Latest Holdings Summary

Lilly Asia Ventures Fund II, L.P. currently owns a total of 1 stock. Lilly Asia Ventures Fund II, L.P. owns 8,545,840 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) as of May 23, 2024, with a value of $53 Million.

Latest Holdings of Lilly Asia Ventures Fund II, L.P.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02235	MicroTech Medical (Hangzhou) Co Ltd	2024-05-23	8,545,840	6.20	52,984,208

Holding Weightings of Lilly Asia Ventures Fund II, L.P.

Lilly Asia Ventures Fund II, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, Lilly Asia Ventures Fund II, L.P. has made a total of 2 transactions in MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in MicroTech Medical (Hangzhou) Co Ltd is the sale of 0 shares on May 23, 2024, which brought Lilly Asia Ventures Fund II, L.P. around $0.

Insider Trading History of Lilly Asia Ventures Fund II, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lilly Asia Ventures Fund II, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lilly Asia Ventures Fund II, L.P. Ownership Network

Ownership Network List of Lilly Asia Ventures Fund II, L.P.

No Data

Ownership Network Relation of Lilly Asia Ventures Fund II, L.P.

Lilly Asia Ventures Fund II, L.P. Owned Company Details

What does MicroTech Medical (Hangzhou) Co Ltd do?

Who are the key executives at MicroTech Medical (Hangzhou) Co Ltd?

Lilly Asia Ventures Fund II, L.P. is the 2201 Interest of corporation controlled by you of MicroTech Medical (Hangzhou) Co Ltd. Other key executives at MicroTech Medical (Hangzhou) Co Ltd include 2101 Beneficial owner OrbiMed Asia Partners V, L.P. , 2201 Interest of corporation controlled by you OrbiMed Asia GP V, L.P. , and 2201 Interest of corporation controlled by you OrbiMed Advisors V Limited .

MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) Insider Trades Summary

Over the past 18 months, Lilly Asia Ventures Fund II, L.P. made no insider transaction in MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235). Other recent insider transactions involving MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) include a net purchase of 4,594,400 shares made by OrbiMed Advisors V Limited , a net purchase of 4,594,400 shares made by OrbiMed Asia Partners V, L.P. , and a net purchase of 4,594,400 shares made by OrbiMed Asia GP V, L.P. .

In summary, during the past 3 months, insiders sold 0 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) in total and bought 13,769,700 shares, with a net purchase of 13,769,700 shares. During the past 18 months, 0 shares of MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) were sold and 34,783,200 shares were bought by its insiders, resulting in a net purchase of 34,783,200 shares.

MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235)'s detailed insider trading history can be found in Insider Trading Tracker table.

MicroTech Medical (Hangzhou) Co Ltd Insider Transactions

No Available Data

Lilly Asia Ventures Fund II, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for Lilly Asia Ventures Fund II, L.P.. Currently GuruFocus does not have mailing address information for Lilly Asia Ventures Fund II, L.P..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.